Insights on Discovery

  1. Enhancing Throughput And Reproducibility In Proteomic Analysis 8/27/2025

    Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.

  2. Improving The Efficiency And Quality Of Advanced Imaging And Analysis 8/27/2025

    Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.

  3. Variant-Aware Off-Target Analysis For Informed Guide RNA Selection 8/5/2025

    See how a multi-step, variant-aware approach to CRISPR-based guide RNA selection systematically reduces off-target risk at each stage, giving researchers greater confidence in their work.

  4. ASCO 2025: Key Takeaways From The American Society Of Clinical Oncology Annual Meeting 7/31/2025

    Cell and gene therapy for cancer continues to advance. New data show promise, alongside discussions on safety and scalability.

  5. Detection Of Rare And Low-Expressing BCMA CAR-T Cells 7/31/2025

    Discover how precise flow cytometric identification of CAR+ cells across diverse models and workflows enables high specificity, flexibility, and sensitivity—even in rare or low-expression populations.

  6. Rapid Production Of Assay Ready Cells For GPCR Drug Discovery 7/29/2025

    Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.

  7. A Novel Cell-Based Assay For Ubiquitin Drug Discovery 7/29/2025

    Learn about a novel cell-based assay that can advance ubiquitin ligase drug discovery. This high-throughput method simplifies assay development, saving time and resources.

  8. High-Throughput Screening Of Ion Channel Variants Using Automated Patch Clamp Recordings In Assay Ready Cells 7/29/2025

    High-throughput screening of KCNQ2 ion channel variants provides insights into epilepsy and treatment responses. This validated method supports rapid characterization for precision medicine.

  9. Risk Assessment Services Align With FDA Guidance For Gene-Edited Human Gene Therapy Products 7/29/2025

    Navigate the FDA's gene therapy guidelines with advanced risk assessment strategies. Optimize gene editing and ensure regulatory alignment for safer, more effective therapies.

  10. Mammalian Display Method For The Development Of Enhanced Affinity TCR-Based Biologics 7/29/2025

    Discover how mammalian display enhances T cell receptor-based cancer therapies. This method improves antigen affinity and reduces immunogenicity for more effective treatments.